The aim of this study was to evaluate the eryptosis level of healthy RBCs treated with different concentrations of urea, p-cresol, IL-6 and IL-1β, comparable to the plasmatic level of CKD and uremic patients at different time points. This evidence concerns the gene IL1B and chronic kidney disease.